v" The combination of metrizamide (Amipaque) ventriculography and vertebral angiography with stereoradiography provided precise localization of an arteriovenous malformation of the velum interpositum and an associated hematoma in the lateral ventricles that bad not been detected by computerized tomography. This dual technique is recommended for precise localization of suspected intra-or periventricular lesions before surgery.
Case Report
This 20-year-old woman was admitted to a community hospital because of a subarachnoid hemorrhage (SAH) followed by coma. Within 2 weeks she gradually became more alert and was able to follow simple commands. A radionuclide brain scan showed a right parietooccipital abnormality. Bilateral carotid angiography demonstrated a deep midline AVM supplied by the posterior cerebral arteries. She was then transferred to Presbyterian-University Hospital.
History. At 8 years of age she had sustained a previous SAH. Bilateral carotid angiography was normal at that time, but air ventriculography showed a large mass in the lateral ventricles. A frontal craniotomy with evacuation of hematoma from both lateral ventricles was followed by an uneventful recovery. She had led an energetic and normal childhood, eventually entering nursing school.
Examination. The patient was lethargic and disoriented. There was marked retrograde and anterograde amnesia. She had a spastic right hemiparesis, right hyperreflexia, right visual field defect, impairment of upward gaze and convergence, and papilledema.
Cranial computerized tomography (CT) soon after admission demonstrated ventriculomegaly and a mass in the region of the posterior third ventricle. No hematoma was visualized. A right frontal ventriculoperitoneal shunt was inserted. Thereafter her mental status improved, but profound impairment of recent memory persisted.
To localize the AVM more precisely before intracranial surgery, combined metrizamide ventriculography and stereoscopic retrograde transfemoral angiography were performed simultaneously. Through a No. 23 needle, 7 cc of metrizamide 190 mg I/ml was injected into the shunt reservoir; immediately thereafter vertebral angiography was performed via a previously positioned vertebral artery catheter. A small AVM of the velum interpositum was clearly demonstrated, supplied by the medial posterior choroidal vessels. In addition, contoured metrizamide filling defects in the lateral ventricles indicated the presence of hematoma (Fig. 1) . No significant side effects were encountered during the study.
Operation. A parasagittal parietooccipital craniotomy was performed 2 weeks after admission. The splenium of the corpus callosum was transected, after which the left lateral ventricle was entered. The hematoma demonstrated on the ventriculogram partially filled the lateral ventricles, and was removed. The malformation was then excised from the base of the left fornix and the velum interpositum without complications.
Discussion
Since the introduction of ventriculography by Dandy in 1918, 8 many contrast materials have been evaluated in a search for the "ideal" positive contrast ventriculographic agent. Thus far, no agent has been found to be completely safe or free from complications.
After the introduction of metrizamide in 1972, it became apparent that this non-ionic water-soluble compound with low osmolality and lipid solubility might be less toxic, 2 and highly applicable to ventriculography, e' 7' 11 Laboratory studies confirmed that intraventricular injection of metrizamide was better tolerated by cats than meglumineiothalamate (Conray) or meglumineiocarmate (Dimeray). x~ Conray produces electroencephalographic spike waves and convulsions when applied to the cortex of experimental animals; however, no evidence of epileptic spikes was seen in the EEG's of 61 patients studied with metrizamide when administered intraventricularly or into the lumbar or cervical subarachnoid space. 7 In addition, Skalpe and Amundsen reported 600 myelograms in 581 patients, none of whom had convulsions. TM The most. common side effects of metrizamide are headache, nausea, and vomiting? ,7,B Headache usually disappears in 48 hours. Transient hypotension and mild cerebrospinal fluid pleocytosis have also been reported. 7-~ No significant reaction has been demonstrated with extradural or extracerebral injections. 7 Late sequelae seen with other agents, such as adhesive arachnoiditis, have yet to be reported with metrizamide. TM In this case, clear delineation of the ventricular system was obtained with 7 ml of metrizamide, 190 mg I/ml (1.33 gm). As much as 3 gm of iodine may be injected with minimal risk in patients with dilated ventricles. TM In patients with an unobstructed ventricular system, dilution of contrast material may result in poor-quality radiography. This can be avoided by injecting higher concentrations into the frontal horn near the foramen of Monro? ~ As illustrated in this case, the simultaneous use of metrizamide ventriculography and stereoangiography may permit precise localization of an AVM before surgery. The finding of an intraventricular hematoma in the present case was unexpected since the CT scan showed no evidence of hemorrhage. The presence of intraventricular hematomas in deep midline AVM's is unusual. In the series of Ya~argil, et al., only one of 10 patients with AVM's of the splenium of the corpus callosum had such a hematoma? TM In our patient, metrizamide ventriculography confirmed the hematoma and its precise extent preoperatively. This technique appears to be valuable when precise definition of the ventricular system is required in midline, vascular, interhemispheric, or intraventricular lesions.
